港股異動 | 營收五年連漲再闖A股 康寧醫院(2120.HK)飆漲超20%
格隆匯9月24日丨康寧醫院(2120.HK)尾盤漲幅擴大至超20%,報36.8港元,總市值27.5億港元。時隔兩年後,“精神病第一股”康寧醫院再次衝刺A股IPO。曾在其港股上市招股書中稱,中國現時有1.8億人患有精神疾病,這個數據引爆了輿論,並讓這隻“精神病第一股”廣為人知。這次能否如願登陸創業板,成為首家A+H精神專科醫院上市公司,值得關注。在2016年~2020年,公司營收持續穩健增長,根據2020年度財報,康寧醫院自有醫院運營收入9.78億元,與2017年相比,規模翻了一番。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.